World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
80
Citations
24556
World Ranking
1619
National Ranking
63

Bart C. Jacobs publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Bart C. Jacobs sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 288 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Bart C. Jacobs D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Bart C. Jacobs sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 80 D-Index — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Bart C. Jacobs is affiliated with Erasmus University Rotterdam in the Netherlands and has a research focus predominantly in the field of Medicine, with a specialization in Neurology.

The scientist's research spans several subfields, including:

  • Neurology
  • Cellular and Molecular Neuroscience
  • Radiology, Nuclear Medicine and Imaging
  • Immunology
  • Pathology and Forensic Medicine

The main topics addressed in their work are diverse and related primarily to neurological disorders and immune responses, including:

  • Peripheral Neuropathies and Disorders
  • Hereditary Neurological Disorders
  • Long-Term Effects of COVID-19
  • Monoclonal and Polyclonal Antibodies Research
  • Peripheral Nerve Disorders
  • Myasthenia Gravis and Thymoma
  • Nerve injury and regeneration

Jacobs has contributed multiple articles to recognized scientific journals with frequent publications in these venues:

  • Neurology
  • Journal of the Peripheral Nervous System
  • Journal of Neurology Neurosurgery & Psychiatry
  • European Journal of Neurology
  • European Journal of Paediatric Neurology

Notable recent papers authored or co-authored by Jacobs include:

  • "Intensive care unit acquired muscle weakness in COVID-19 patients" (2020) published in Intensive Care Medicine
  • "European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome" (2023) published in European Journal of Neurology
  • "Tight Blood-Glucose Control without Early Parenteral Nutrition in the ICU" (2023) published in New England Journal of Medicine
  • "COVID-19 vaccine and Guillain-Barré syndrome: let's not leap to associations" (2020) published in Brain
  • "Guillain-Barré syndrome: expanding the concept of molecular mimicry" (2022) published in Trends in Immunology

Bart C. Jacobs has collaborated frequently with a range of co-authors, including:

  • Pieter A. van Doorn
  • Sonja E. Leonhard
  • Luís Querol
  • Ruth Huizinga
  • Hugh J. Willison

Best Publications

  • Guillain-Barré syndrome.

    Hugh J Willison;Bart C Jacobs;Pieter A van Doorn

  • Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis

    Bianca van den Berg;Christa Walgaard;Judith Drenthen;Christiaan Fokke

  • The spectrum of antecedent infections in Guillain-Barré syndrome: A case-control study

    B. C. Jacobs;P. H. Rothbarth;F.G.A. van der Meché;P. Herbrink

  • Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome.

    Pieter A van Doorn;Liselotte Ruts;Bart C Jacobs

  • The Guillain–Barré syndrome: a true case of molecular mimicry

    C. Wim Ang;Bart C. Jacobs;Jon D. Laman

  • Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.

    Bart C. Jacobs;Pieter A. van Doorn;Anne P. Tio-Gillen;Leo H. Visser

  • Guillain-Barré syndrome associated with preceding hepatitis E virus infection.

    Bianca van den Berg;Annemiek A. van der Eijk;Suzan D. Pas;Jeremy G. Hunter

  • Cytomegalovirus infection and Guillain-Barre syndrome: The clinical, electrophysiologic, and prognostic features

    L. H. Visser;F. G. A. Van Der Meche;J. Meulstee;P. P. Rothbarth

  • Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.

    Susan K. Halstead;Femke M. P. Zitman;Peter D. Humphreys;Kay Greenshields

  • The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barré syndrome

    Peggy C.R. Godschalk;Astrid P. Heikema;Michel Gilbert;Tomoko Komagamine

  • Hepatitis E virus and neurological injury

    Harry R. Dalton;Harry R. Dalton;Nassim Kamar;Jeroen J. J. van Eijk;Brendan N. Mclean

  • Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome

    Krista Kuitwaard;Jenny de Gelder;Anne P. Tio-Gillen;Wim C. J. Hop

  • Hepatitis E virus: Infection beyond the liver?

    Sven Pischke;Johannes Hartl;Suzan D. Pas;Ansgar W. Lohse

  • Axonal variant of Guillain-Barré syndrome associated with Campylobacter infection in Bangladesh

    Z. Islam;B. C. Jacobs;A. van Belkum;Q. D. Mohammad

  • Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates.

    J. J. Plomp;P. C. Molenaar;G. M. O'hanlon;B. C. Jacobs

  • Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy.

    Carina Bunschoten;Bart C Jacobs;Peter Y K Van den Bergh;David R Cornblath

  • Neuralgic amyotrophy and hepatitis E virus infection

    Jeroen J.J. van Eijk;Richie G. Madden;Annemiek A. van der Eijk;Jeremy G. Hunter

  • Serum anti‐GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome

    B. C. Jacobs;H. P. Endtz;F. G. A. Van Der Meche;M. P. Hazenberg

  • A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain–Barré syndrome

    R. Louwen;D. Horst-Kreft;A. G. de Boer;L. van der Graaf

  • Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis

    Merel C Broers;Carina Bunschoten;Daan Nieboer;Hester F Lingsma

  • Structure of Campylobacter jejuni Lipopolysaccharides Determines Antiganglioside Specificity and Clinical Features of Guillain-Barré and Miller Fisher Patients

    C. W. Ang;J. D. Laman;H. J. Willison;E. R. Wagner

Frequent Co-Authors

Hubert P. Endtz
Hubert P. Endtz Erasmus University Rotterdam
Hugh J. Willison
Hugh J. Willison University of Glasgow
P.A. van Doorn
P.A. van Doorn Erasmus University Rotterdam
Alex van Belkum
Alex van Belkum BaseClear B.V.
Hester F. Lingsma
Hester F. Lingsma Erasmus University Rotterdam
Michel Gilbert
Michel Gilbert National Academies of Sciences, Engineering, and Medicine
Jon D. Laman
Jon D. Laman University Medical Center Groningen
Jaap A. Wagenaar
Jaap A. Wagenaar Utrecht University
David R. Cornblath
David R. Cornblath Johns Hopkins University School of Medicine
Jaap J. Plomp
Jaap J. Plomp Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring complementary healthcare degrees can broaden career opportunities. Many professionals transition into nursing roles, where understanding the immune system is crucial. If you're new to nursing, consider online adn programs for non nurses that offer accessible pathways into nursing without prior experience.

For accelerated options, especially if you already hold a degree, the 12-month accelerated nursing programs provide fast-tracked education designed to meet workforce demand without sacrificing quality.

Entry-level roles like Licensed Practical Nurse (LPN) offer a quicker route into healthcare, with many options available among easy lpn programs to get into. These programs prepare graduates for hands-on patient care roles that often collaborate with immunology specialists.

For advanced practice, particularly in clinical settings related to immunological health, exploring nurse practitioner programs with easy admission can be a strategic choice. These programs emphasize critical thinking and advanced medical knowledge, including immunological conditions.

Best Scientists Citing Bart C. Jacobs

Trending Scientists

Recently Published Articles